Company: SCAG
Filing Date: 2025-01-06
Form Type: 424B3
Source: 0001213900-25-001215
Chunk: 197

Company: Scage Future
Filing Date: 2025-01-06
Form: 424B3
Chunk 197
---
 of the aforementioned persons and the consideration received by each party in connection with such arrangements. Any such report will include (i) the amount of Finnovate Ordinary Shares purchased and the purchase price; (ii) the purpose of such purchases; (iii) the impact of such purchases on the likelihood that the Business Combination transaction will be approved; (iv) the identities or characteristics of security holders who sold shares if not purchased in the open market or the nature of the sellers; and (v) the number of Finnovate Ordinary Shares for which Finnovate has received redemption requests. Entering into any such incentive arrangements may have a depressive effect on outstanding Finnovate Ordinary Shares. For example, as a result of these arrangements, an investor or holder may have the ability to effectively purchase shares at a price lower than market and may therefore be more likely to sell the shares he or she owns, either prior to or immediately after the Meeting. 72 Entering into any such incentive arrangements may have a depressive effect on Finnovate Ordinary Shares. For example, as a result of these arrangements, an investor or holder may have the ability to effectively purchase shares at a price lower than market and may therefore be more likely to sell the shares he owns, either prior to or immediately after the Extraordinary General Meeting. In addition, if such purchases are made, the public float of Finnovate Ordinary Shares or Finnovate Warrants and the number of beneficial holders of Finnovate securities may be reduced, possibly making it difficult to maintain the quotation, listing or trading of Finnovate securities on Nasdaq. Since we have not consummated our initial Business Combination by November 4, 2024, our securities have been suspended from trading on Nasdaq and will be delisted. Such trading suspension or delisting could have a material adverse effect on the trading of our securities and may adversely affect our ability to consummate an initial Business Combination. On September 12, 2023, Finnovate received a deficiency notice from the Listing Qualifications Department (the “Staff”) of Nasdaq notifying Finnovate that it was not in compliance with Nasdaq’s continuing listing standards (the “Listing Rules”) as set forth in in Listing Rule 5250(c)(1) given Finnovate’s failure to timely file its quarterly report on Form 10 -Qfor the period ended June 30, 2023. The notification received had no immediate effect on Finnovate’s Nasdaq listing. In accordance with Nasdaq rules, we